Chlorpyrifos induces delayed cytotoxicity after withdrawal in primary hippocampal neurons through extracellular signal-regulated kinase inhibition

Biological and Pharmaceutical Bulletin

Volumn 32, Issue 10, 2009, Pages 1649-1655

  Tan, De Hong ^a,b   Peng, Shuang Qing ^a   Wu, Ying Liang ^b   Wang, Yi Mei ^a   Lu, Chun Feng ^a,b   Ding, Wei ^a   Wang, Qiao Xu ^a   Yan, Chang Hui ^a  

^a BEIJING INSTITUTE OF MICROBIOLOGY AND EPIDEMIOLOGY   (China)

^b SHENYANG PHARMACEUTICAL UNIVERSITY   (China)

Author keywords

Acetylcholinesterase; Chlorpyrifos; Hippocampal neuron; Organophosphorus; Pesticide

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; ATROPINE; CARBACHOL; CHLORPYRIFOS; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; NERVE GROWTH FACTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN NERVE CELL; CELL LOSS; CONTROLLED STUDY; CYTOTOXICITY; ENZYME ACTIVATION; ENZYME INHIBITION; ENZYME PHOSPHORYLATION; HIPPOCAMPUS; IMMUNOHISTOCHEMISTRY; NERVE CELL CULTURE; NEUROPROTECTION; NEWBORN; NICK END LABELING; NONHUMAN; RAT;

ANIMALS; ATROPINE; CARBACHOL; CHLORPYRIFOS; CHOLINERGIC AGONISTS; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; FLAVONOIDS; HIPPOCAMPUS; IN SITU NICK-END LABELING; INSECTICIDES; NERVE GROWTH FACTOR; NEURONS; PHOSPHOPYRUVATE HYDRATASE; PHOSPHORYLATION; RATS; RATS, SPRAGUE-DAWLEY;

EID: 70349952318     PISSN: 09186158     EISSN: 13475215     Source Type: Journal    
DOI: 10.1248/bpb.32.1649     Document Type: Article

References (39)

1. Raheja G., Gill K. D., Toxicol. Ind. Health, 23, 25-37 (2007).
2. Wesseling C., Keifer M., Ahlborn A., McConeel R., Moon J., Risenstock L., Hogstedt C., Int. J. Occup. Health, 8, 27-34 (2002).
3. Jamal G. A., Adverse Drug React. Toxicol. Rev., 16, 133-170 (1997).
4. Abou-Donia M. B., Arch. Environ. Health, 58, 484-497 (2003).
5. Colosio C., Tiramani M., Maroni M., Neurotoxicology, 24, 577-591 (2003).
6. Storm J. E., Rozman K. K., Doull J., Toxicology, 150, 1-29 (2000).
7. Rosenstock L., Keifer M., Daniell W., McConnell R., Claypoole K., Lancet, 338, 223-227 (1991).
8. Cañadas F., Cardona D., Dávila E., Sánchez-Santed F., Toxicol. Sci., 85, 944-951 (2005).
9. Kassa J., Koupilova M., Vachek J., Pharmacol. Biochem. Behav., 70, 175-179 (2001).
10. Kamel F., Hoppin J. A., Environ. Health Perspect., 112, 950-958 (2004).
11. Stephens R., Spurgeon A., Berry H., Neurotoxicol. Teratol., 18, 449-453 (1996).
12. Bazylewicz-Walczak B., Majczakowa W., Szymczak M., Neurotoxicology, 20, 819-826 (1999).
13. Song X., Seidler F. J., Saleh J. L., Zhang J., Padilla S., Slotkin T. A., Toxicol. Appl. Pharmacol., 145, 158-174 (1997).
14. Prendergast M. A., Terry A. V., Buccafusco J. J., Psychopharmacology (Berlin), 129, 183-191 (1997).
15. Sánchez-Santed F., Cañadas F., Flores P., López-Grancha M., Cardona D., Neurotoxicol. Teratol., 26, 305-317 (2004).
16. Terry A. V., Stone J. D., Buccafusco J. J., Sickles D. W., Sood A., Prendergast M. A., J. Pharmacol. Exp. Ther., 305, 375-384 (2003).
17. Zurich M. G., Honegger P., Schilter B., Costa L. G., Monnet-Tschudi F., Toxicol. Appl. Pharmacol., 201, 97-104 (2004).
18. Caughlan A., Newhous K., Namgung U. K., Xia Z., Toxicol. Sci., 78, 125-134 (2004).
19. Eichenbaum H., Neuron, 44, 109-120 (2004).
20. Gron G., Brandenburg I., Wunderlich A. P., Riepe M. W., Neurobiol. Aging, 27, 78-87 (2006).
21. Zhang M., Wang A., He W., He P., Xu B., Xia T., Chen X., Yang K., Toxicology, 236, 208-216 (2007).
22. Schengrund C., Marangos P., J. Neurosci., 5, 305-311 (2004).
23. Mosmann T., J. Immunol. Methods, 65, 55-63 (1983).
24. Wang W., Iyo A., Miguel-Hidalgoa J., Regunathana S., Zhu M., Brain Res., 1084, 210-216 (2006).
25. Rosenblum K., Futter M., Jones M., Hulme E. C., Bliss T. V., J. Neurosci., 20, 977-985 (2000).
26. Yan G. M., Lin S. Z., Irwin R. P., Paul S. M., Mol. Pharmacol., 47, 248-257 (1995).
27. Atkins C. M., Selcher J. C., Petraitis J. J., Trzaskos J. M., Sweatt J. D., Nat. Neurosci., 1, 602-609 (1998).
28. Robinson M. J., Cobb M. H., Curr. Opin. Cell Biol., 9, 180-186 (1997).
29. Hetman M., Kanning K., Cavanaugh J. E., Xia Z., J. Biol. Chem., 274, 22569-22580 (1999).
30. Szatmari E., Kalita K. B., Kharebava G., Hetman M., J. Neurosci., 27, 11389-11400 (2007).
31. Araki W., Wurtman R. J., Mol. Brain Res., 56, 169-177 (1998).
32. Xia Z., Dickens M., Raingeaud J., Davis R. J., Greenberg M. E., Science, 270, 1326-1331 (1995).
33. Alessandrini A., Namura S., Moskowitz M. A., Bonventre J. V., Proc. Natl. Acad. Sci. U.S.A., 96, 12866-12869 (1999).
34. Murray B., Alessandrini A., Cole A., Yee A., Furshpan E., Proc. Natl. Acad. Sci. U.S.A., 95, 11975-11980 (1998).
35. Stanciu M., Wang Y., Kentor R., Burke N., Watkins S., Kress G., Reynolds I., Klann E., Angiolieri M. R., Johnson J. W., DeFranco D. B., J. Biol. Chem., 275, 12200-12206 (2000).
36. Takagi N., Miyake-Takagi K., Takagi K., Tamura H., Takeo S., J. Biol. Chem., 277, 6382-6390 (2002).
37. Thoenen H., Science, 270, 593-598 (1995).
38. Bowden C. A., Krenzelok E. P., Drug Saf., 16, 9-47 (1997).
39. Alessi D. A., Cuenda A., Cohen P., Dudley D. T., Saltiel A. R., J. Biol. Chem., 270, 27489-27494 (1995).